Eve image

Consumer Health Data Privacy Policy

STAAR SURGICAL CONSUMER HEALTH DATA PRIVACY POLICY

Last Updated: October 30, 2026

INTRODUCTION

STAAR Surgical Company and our global subsidiaries and affiliates (collectively, “STAAR,” “we,” “us,” and “our”) are committed to respecting your privacy. This Consumer Health Data Privacy Policy supplements the STAAR Surgical Privacy Policy and applies to personal data defined as “consumer health data” subject to the Washington State My Health My Data Act. 

CONSUMER HEALTH DATA COLLECTED

Consumer health data means personal information that is linked or reasonably linkable to a consumer and that identifies the consumer’s past, present, or future physical or mental health status. The consumer health data we collect depends on the context of your interaction with us. Examples of consumer health data we may collect in the course of providing our services include information about an individual’s:

  • health conditions, treatment, diseases, or diagnoses (e.g., vision disorders);
  • medical interventions;
  • use or purchase of medications or prescribed medications;
  • measurements of health information (e.g., eye measurements);
  • diagnoses or diagnostic testing, treatment, or medication; or
  • information that could identify an individual seeking health care services or information. 

SOURCES OF CONSUMER HEALTH DATA

We collect consumer health data from the following sources:

  • directly from you when you interact with us or use our services;
  • automatically through cookies and other tracking technologies that reveal your interest in our services; or
  • from third parties such as healthcare providers who provide health data to us pursuant to your authorization.

PURPOSES FOR COLLECTION AND USE

Our collection of consumer health data is necessary for the provision of our services. In addition, we may use consumer health data to compile analytics, improve our services, comply with legal and regulatory obligations, for any other purpose with your consent, or otherwise as described in the STAAR Surgical Privacy Policy.

DISCLOSURE OF CONSUMER HEALTH DATA

In addition to sharing consumer health data with our service providers, we may share consumer health data with the following third parties:

  • Our affiliates listed in Annex I below.
  • Certain third parties with your consent or at your direction. These parties may include healthcare providers.
  • Other third parties to protect our rights, defend or pursue a legal claim, or investigate or prosecute illegal activities.
  • Government or judicial authorities or agencies to comply with a subpoena, court order, governmental inquiry, legal process, legal obligation, or to protect the rights, property, or safety of other users or the public, including mandatory disclosures to public health authorities or adverse event reporting to regulatory agencies.

We may also share consumer health data with a successor entity or purchaser upon a merger, consolidation, or other corporate reorganization in which we participate, or pursuant to a financing arrangement. 

YOUR RIGHTS

Washington residents have the following rights with respect to their consumer health data, subject to certain exceptions:

  • the right to confirm whether we process your consumer health data, and to access and receive a copy of your consumer health data;
  • the right to a list of all third parties and affiliates with whom we have shared or sold your consumer health data and an email address or other online mechanism that you can use to contact each third party;
  • the right to delete your consumer health data; and
  • the right to withdraw consent to the collection, sharing, or selling of consumer health data.

You can submit a request to exercise these rights using any of the mechanisms listed in the “Contact Information” section below. Depending on the type of request, we may need to verify your request before we can fulfill it. Please note that certain exceptions may apply to these rights (e.g., we may be unable to honor a request to delete if it conflicts with a legal obligation to retain data). Finally, please review the STAAR Surgical Privacy Policy for additional rights and choices you may have with respect to your personal data more generally.

You have the right to appeal any decisions we make in response to a rights request. If your appeal is unsuccessful, you can raise a concern or lodge a complaint with the Washington State Attorney General at www.atg.wa.gov/file-complaint.

 

CHANGES TO THIS POLICY

We may revise this policy from time to time. When we make changes to this policy, we will post the updated version on our website and indicate the date the policy was last updated. We encourage you to review this policy periodically to check for any updates.

CONTACT INFORMATION

If you have questions or concerns regarding this policy or wish to exercise your privacy rights, please contact us at:

STAAR Surgical Company

25510 Commercentre Drive, Ste. 200, Lake Forest, California 92630, USA

Phone: 1.626.303.7902

Email: PrivacyOffice@staar.com

SUPPLEMENT TO CONSUMER HEALTH DATA PRIVACY POLICY FOR NEVADA CONSUMERS

This supplement to our Consumer Health Data Privacy Policy applies to Nevada residents for purposes of providing additional disclosures required by Nevada’s consumer health data privacy law (Nevada Senate Bill 370).

The foregoing consumer health data disclosures and rights also apply to Nevada residents. In addition, Nevada residents also have the right to review and amend any consumer health data we maintain about them. Nevada residents can escalate unsuccessful appeals of consumer rights requests to the Nevada attorney general at https://ag.nv.gov/Complaints/CSU_Complaints___FAQ/. Third parties may collect consumer health data over time and across different websites when you use our websites.

ANNEX I: LIST OF RELEVANT STAAR ENTITIES

  1. STAAR Surgical Company (Delaware, United States)
  2. STAAR Surgical AG (Nidau, Switzerland)

اطلاعات ایمنی مهم

Evo و EVO ICL برای درمان نزدیک‌بینی متوسط به بالا طراحی شده است (0.5- تا 20.0- دیوپتر) و کاهش نزدیک‌بینی در بیمارانی که تا -20 دیوپتر نزدیک‌بینی دارند، و آستیگماتیسم کمتر از 6.0 دیپوتر یا برابر با آن. این روش برای بیماران 21 تا 45 سال مناسب است. برای این که جراح شما بتواند از یک لنز EVO با بهترین توان این روش جهت بهبود چشم‌تان استفاده کند، نزدیک‌بینی چشم شما باید حداقل یک سال قبل از عمل ثابت مانده باشد. EVO به عنوان یک روش ایمن و کارامد برای درمان نزدیک‌بینی از 0.5- تا 20.0- دیوپتر، و آستیگماتیسم 6.0 دیوپتر یا کمتر، و نیز درمان بخشی از آستیگماتیسم بیش از 20.0- دیوپتر و آستیگماتیسم بالای 6.0- مناسب است. این روش برای اصلاح هر نوع آستیگماتیسمی که شما اکنون یا در گذشته داشته‌اید به کار نمی‌آید.

اگر شما در این محدوده دچار نزدیک‌بینی هستید، عمل EVO ممکن است بدون استفاده از عینک یا لنز تماسی، دید دور شما را بهبود بخشد. جراحی EVO نیاز به عینک مطالعه را از بین نمی‌برد، حتی اگر قبلاً هیچگاه این عینک‌ها را به چشم نزده باشید. EVO را به عنوان جایگزینی برای دیگر جراحی‌های عیوب انکساری از قبیل لیزر در ضخامت قرنیه (لیزیک) و فوتوریفرکتیو کراتکتومی (PRK)، جراحی‌های برشی، یا دیگر ابزار درمان نزدیک‌بینی از قبیل لنزهای تماسی یا عینک طبی در نظر می‌گیرند. EVO برای درمان آستیگماتیسم که ممکن است شما داشته باشید، به کار نمی‌آید. کاشت EVO نوعی عمل جراحی است و به همین دلیل، ریسک‌های جدی بالقوه‌ی خودش را دارد. لطفاً در مورد این خطرات، با چشم‌پزشک خود گفتگو کنید.

عوارض بالقوه و مشکلات جانبی جراحی انکساری به طور کلی در زیر آمده است:

التهاب ملتحمه، ورم حاد قرنیه، ورم مداوم قرنیه، اندوفتالمیت (عفونت کل چشم)، حساسیت قابل توجه به نور و / یا هاله در اطراف نور، هایفما (خونریزی در چشم)، هیپوپیون (چرک چشم)، عفونت چشم، تغییر وضعیت لنز Evo Visian ICL، ادم ماکولا، مردمک غیرواکنشی، مردمک گلوکوم بلوک، التهاب شدید چشم، ورم عنبیه، یووئیت، از دست دادن شفافیت و پیوند قرنیه. پیش از انجام جراحی EVO، چشمان شما باید به طور کامل معاینه گردد. با چشم‌پزشک‌تان درباره جراحی EVO صحبت کنید، و به ویژه مزایا، خطرات و عوارض احتمالی آن را از او جویا شوید. شما باید در مورد زمان مورد نیاز برای بهبودی پس از عمل جراحی نیز با او گفتگو کنید.


منابع

References

1Visian ICL Patient Information Booklet

2Sanders D. Vukich JA. Comparison of implantable collamer lens (ICL) and laser-assisted in situ keratomileusis (LASIK) for Low Myopia. Cornea. 2006 Dec; 25(10):1139-46.

3Naves, J.S. Carracedo, G. Cacho-Babillo, I. Diadenosine Nucleotid Measurements as Dry-Eye Score in Patients After LASIK and ICL Surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.

4Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6.

5Lee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. Journal of Cataract & Refractive Surgery , Volume 26 , Issue 9 , 1326 - 1331.

6Parkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.

*American Refractive Surgery Council